Carregant...
2-Oxoamide inhibitors of cytosolic group IVA phospholipase A(2) with reduced lipophilicity
Cytosolic GIVA phospholipase A(2) (GIVA cPLA(2)) initiates the eicosanoid pathway of inflammation and thus inhibitors of this enzyme constitute novel potential agents for the treatment of inflammatory diseases. Traditionally, GIVA cPLA(2) inhibitors have suffered systemically from high lipophilicity...
Guardat en:
| Publicat a: | Bioorg Med Chem |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5014611/ https://ncbi.nlm.nih.gov/pubmed/27522578 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bmc.2016.07.057 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|